Catalyst Wire Dossier Catalyst Wire Dossier

Lasofoxifene

Lasofoxifene · Sermonix Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Lasofoxifene, covering 2011-08-10 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation [Phase 3]

See pricing